Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients

Tobramycin powder for inhalation (TOBI Podhaler or TIP) is approved for the treatment of Pseudomonas aeruginosa airway infection in patients with cystic fibrosis (CF). A population pharmacokinetic model for tobramycin inhalation powder (TIP) in CF patients was developed to characterize the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, L, Aksenov, S, Bhansali, S G, Ramakrishna, R, Tang, P, Geller, D E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944114/
https://www.ncbi.nlm.nih.gov/pubmed/24522146
http://dx.doi.org/10.1038/psp.2013.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944114/
https://www.ncbi.nlm.nih.gov/pubmed/24522146
http://dx.doi.org/10.1038/psp.2013.76

Ejemplares similares